{
    "Trade/Device Name(s)": [
        "BreathID\u00ae Hp System"
    ],
    "Submitter Information": "Exalenz Bioscience Ltd.",
    "510(k) Number": "K173772",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130524"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MSQ",
        "JJQ"
    ],
    "Summary Letter Date": "December 1, 2017",
    "Summary Letter Received Date": "December 12, 2017",
    "Submission Date": "March 7, 2018",
    "Regulation Number(s)": [
        "866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Helicobacter pylori"
    ],
    "Specimen Type(s)": [
        "Exhaled breath"
    ],
    "Specimen Container(s)": [
        "Nasal cannula"
    ],
    "Instrument(s)/Platform(s)": [
        "BreathID\u00ae Hp device"
    ],
    "Method(s)/Technology(ies)": [
        "Molecular Correlation Spectroscopy (MCS)",
        "Optical absorption spectroscopy"
    ],
    "Methodologies": [
        "Measurement of 13CO2/12CO2 ratio in breath"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Kit",
        "Test device",
        "Cannula"
    ],
    "Document Summary": "FDA 510(k) summary for Exalenz BreathID\u00ae Hp System for noninvasive detection and monitoring of Helicobacter pylori infection using breath-based 13CO2/12CO2 ratio analysis",
    "Indications for Use Summary": "Aid in initial diagnosis and post treatment monitoring of H. pylori infection in adult and pediatric patients ages 3-17 years by noninvasive measurement of exhaled breath 13CO2/12CO2 ratio, administered by trained healthcare professionals under physician supervision",
    "fda_folder": "Microbiology"
}